Jacobs Levy Equity Management, Inc Sangamo Therapeutics, Inc Transaction History
Jacobs Levy Equity Management, Inc
- $23.9 Billion
- Q1 2025
A detailed history of Jacobs Levy Equity Management, Inc transactions in Sangamo Therapeutics, Inc stock. As of the latest transaction made, Jacobs Levy Equity Management, Inc holds 1,297,785 shares of SGMO stock, worth $674,848. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,297,785
Previous 742,462
74.79%
Holding current value
$674,848
Previous $757,000
13.08%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding SGMO
# of Institutions
140Shares Held
55.7MCall Options Held
2.22MPut Options Held
1.82M-
Vanguard Group Inc Valley Forge, PA9.37MShares$4.87 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT8.08MShares$4.2 Million0.02% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny6.84MShares$3.56 Million0.01% of portfolio
-
Black Rock Inc. New York, NY4.7MShares$2.45 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.33MShares$1.21 Million0.0% of portfolio
About SANGAMO THERAPEUTICS, INC
- Ticker SGMO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 156,552,992
- Market Cap $81.4M
- Description
- Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...